» Articles » PMID: 24818957

Physiological Bases of the K+ and the Glutamate/GABA Hypotheses of Epilepsy

Overview
Journal Epilepsy Res
Specialty Neurology
Date 2014 May 14
PMID 24818957
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Epilepsy is a heterogeneous family of neurological disorders that manifest as seizures, i.e. the hypersynchronous activity of large population of neurons. About 30% of epileptic patients do not respond to currently available antiepileptic drugs. Decades of intense research have elucidated the involvement of a number of possible signaling pathways, however, at present we do not have a fundamental understanding of epileptogenesis. In this paper, we review the literature on epilepsy under a wide-angle perspective, a mandatory choice that responds to the recurrent and unanswered question about what is epiphenomenal and what is causal to the disease. While focusing on the involvement of K+ and glutamate/GABA in determining neuronal hyperexcitability, emphasis is given to astrocytic contribution to epileptogenesis, and especially to loss-of-function of astrocytic glutamine synthetase following reactive astrogliosis, a hallmark of epileptic syndromes. We finally introduce the potential involvement of abnormal glycogen synthesis induced by excess glutamate in increasing susceptibility to seizures.

Citing Articles

Metabolomic Profile Modification in the Cerebellum of Mice Repeatedly Exposed to Khat and Treated with β-Lactamase Inhibitor, Clavulanic Acid.

Alanezi A Metabolites. 2024; 14(12).

PMID: 39728507 PMC: 11679925. DOI: 10.3390/metabo14120726.


Development of a novel glucose-dendrimer based therapeutic targeting hyperexcitable neurons in neurological disorders.

Sharma A, Sah N, Sharma R, Vyas P, Liyanage W, Kannan S Bioeng Transl Med. 2024; 9(5):e10655.

PMID: 39553433 PMC: 11561801. DOI: 10.1002/btm2.10655.


Adrenergic receptor system as a pharmacological target in the treatment of epilepsy (Review).

Ozdemir E Med Int (Lond). 2024; 4(2):20.

PMID: 38476984 PMC: 10928664. DOI: 10.3892/mi.2024.144.


Effect of chronic maternal L-Glu intake during gestation and/or lactation on oxidative stress markers, AMPA Glu1 receptor and adenosine A signalling pathway from foetal and neonatal cerebellum.

Tejero A, Leon-Navarro D, Martin M Purinergic Signal. 2023; 20(2):181-192.

PMID: 37458955 PMC: 10997561. DOI: 10.1007/s11302-023-09959-6.


Neurovascular coupling is optimized to compensate for the increase in proton production from nonoxidative glycolysis and glycogenolysis during brain activation and maintain homeostasis of pH, pCO, and pO.

DiNuzzo M, Dienel G, Behar K, Petroff O, Benveniste H, Hyder F J Neurochem. 2023; 168(5):632-662.

PMID: 37150946 PMC: 10628336. DOI: 10.1111/jnc.15839.


References
1.
van der Hel W, Notenboom R, Bos I, van Rijen P, van Veelen C, De Graan P . Reduced glutamine synthetase in hippocampal areas with neuron loss in temporal lobe epilepsy. Neurology. 2005; 64(2):326-33. DOI: 10.1212/01.WNL.0000149636.44660.99. View

2.
Payne J, Rivera C, Voipio J, Kaila K . Cation-chloride co-transporters in neuronal communication, development and trauma. Trends Neurosci. 2003; 26(4):199-206. DOI: 10.1016/S0166-2236(03)00068-7. View

3.
Beguin P, Crambert G, Monnet-Tschudi F, Uldry M, Horisberger J, Garty H . FXYD7 is a brain-specific regulator of Na,K-ATPase alpha 1-beta isozymes. EMBO J. 2002; 21(13):3264-73. PMC: 125393. DOI: 10.1093/emboj/cdf330. View

4.
Kuga N, Sasaki T, Takahara Y, Matsuki N, Ikegaya Y . Large-scale calcium waves traveling through astrocytic networks in vivo. J Neurosci. 2011; 31(7):2607-14. PMC: 6623677. DOI: 10.1523/JNEUROSCI.5319-10.2011. View

5.
Jorge B, Campbell C, Miller A, Rutter E, Gurnett C, Vanoye C . Voltage-gated potassium channel KCNV2 (Kv8.2) contributes to epilepsy susceptibility. Proc Natl Acad Sci U S A. 2011; 108(13):5443-8. PMC: 3069171. DOI: 10.1073/pnas.1017539108. View